University of the Witwatersrand: Urgent Tuberculosis Vaccine Trial Commences in South Africa
She joins fellow Principal Investigator, Professor Willem Hanekom from the Africa Health Research Institute (AHRI), who will lead the large Phase 3 trial that will evaluate whether the M72/AS01E vaccine candidate can protect older…